Abzena raises £20 million in connection with forthcoming admission to AIM

Mercia EIS Funds | 9th July, 2014
Abzena raises £20 million in connection with forthcoming admission to AIM
Mercia EIS Funds | 18th June, 2014
Abzena intention to float
Mercia EIS Funds | 10th June, 2014
Mercia Fund Management makes £150,000 investment in Dab Gaming
Mercia EIS Funds | 6th June, 2014
Antitope and Baylor Institute for Immunology Research to Collaborate to Produce Manufacturing Cell Line for Novel Therapeutic Dendritic-cell-targeting Vaccine
Mercia EIS Funds | 4th June, 2014
Mercia Fund Management launches start-up competition
Mercia EIS Funds | 3rd June, 2014
PsiOxus Therapeutics announces positive study results of oncolytic vaccine enadenotucirev at 2014 ASCO Annual Meeting
Mercia EIS Funds | 27th May, 2014
PolyTherics and Antitope form Abzena
Mercia EIS Funds | 19th May, 2014
BioExtractions Wales completes funding round for innovative extraction service
Mercia EIS Funds | 14th May, 2014
Mercia Fund Management launches flexible, cost effective workspace for early stage gaming and technology businesses
Mercia EIS Funds | 12th May, 2014
Mercia Fund Management agrees second stage funding for VirtTrade